IDEX 配当と自社株買い
配当金 基準チェック /46
IDEX配当を支払う会社であり、現在の利回りは1.25%で、収益によって十分にカバーされています。
主要情報
1.2%
配当利回り
1.7%
バイバック利回り
| 総株主利回り | 2.9% |
| 将来の配当利回り | 1.4% |
| 配当成長 | 7.9% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | 41% |
最近の配当と自社株買いの更新
Recent updates
IEX: Strong Buy Ratings And Ongoing Buybacks Will Support Future Returns
Analysts have increased their price target for IDEX to $254.50 from $248, reflecting updated assumptions for revenue growth, profit margins and a slightly different discount rate, while leaving long term P/E expectations broadly unchanged. What’s in the News for IDEX Analysts at RBC Capital have kept a Buy rating on IDEX Corporation and set a price target of US$280, according to recent research coverage.IEX: Ongoing Buybacks And Long Dividend Streak Will Support Future Returns
Analysts have raised their price target for IDEX to $248 from $238.29, citing updated assumptions that reflect the latest views on growth, profitability, and valuation multiples. What’s in the News for IDEX IDEX reported that from April 1, 2026 to June 30, 2026, the company repurchased 364,270 shares for US$77 million, representing 0.49% of its shares under an ongoing buyback program.IDEX Corporation: Healthy End-Market Demand Supports Growth, But Premium Valuation Warrants Caution
Summary IDEX Corporation is rated Hold, as its premium P/E valuation is not justified by growth relative to peers. Strong HST segment growth and AI-driven demand should drive FY2026 revenue, but FMT segment weakness remains a headwind. Margins benefit from volume leverage and favorable price/cost, but unfavorable mix and low-margin acquisitions pressure profitability. With a 26.48x P/E versus a 21.8x peer median, IEX's superior margins do not warrant the current valuation premium. Read the full article on Seeking AlphaIdex (IEX) Stock Valuation Check After Recent Gains And Conflicting P/E And DCF Signals
Recent performance snapshot and what it means for IDEX (IEX) IDEX (IEX) has drawn fresh attention after a steady run, with the stock last closing at US$222.04 and total return figures highlighting how the company has been tracking over different holding periods. Over the past month, IDEX shows a 6.9% return, and about 16.6% over the past 3 months, with year to date performance at 24% and a 1 year total return of 25.3%. Longer holding periods show total returns of 10.3% over 3 years and 9%...IEX: Steady Buybacks And Dividend Record Will Support Future Returns
Analysts have nudged their price target on IDEX slightly higher to about $238 per share, reflecting small adjustments to fair value, discount rate, long term revenue growth, profit margin, and future P/E assumptions in their models. What's in the News IDEX's board approved a regular quarterly cash dividend of US$0.73 per common share, scheduled for payment on June 5, 2026, to shareholders of record on May 22, 2026, marking the company’s 126th consecutive regular quarterly dividend (Key Developments).IEX: Dividend Strength And AI-Driven Demand Should Support Future Returns
Analysts have maintained their $237.71 price target for IDEX, citing only very small adjustments in the discount rate, revenue growth, profit margin, and future P/E assumptions as the reasons for leaving their valuation unchanged. What's in the News IDEX reported first quarter fiscal 2026 results that came in stronger than expected, according to recent Wall Street coverage.IEX: Dividend Strength And Buybacks Will Support Returns Going Forward
Analysts have adjusted their price target on IDEX to $237.71 from $222.71, reflecting updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News IDEX Corporation's Board of Directors approved a regular quarterly cash dividend of $0.73 per common share, scheduled to be paid on June 5, 2026, to shareholders of record on May 22, 2026.IEX: Balanced Outlook As Buybacks And M&A Plans Will Shape Returns
Analysts now project only a slight reduction in IDEX's fair value estimate, with the updated price target moving from about $222.93 to $222.71. This reflects modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E.IEX: Balanced Outlook As Buybacks And M&A Plans Shape Future Returns
Analysts have inched their price target for IDEX lower to about $223 from roughly $224, reflecting slightly revised assumptions on fair value, discount rate and forward P/E, while keeping revenue growth and profit margin expectations broadly unchanged. What's in the News IDEX completed a share repurchase tranche from October 1, 2025 to February 19, 2026, buying 632,280 shares for US$113.1 million, equal to 0.84% of shares under the existing program (Key Developments).IEX: Ongoing Buybacks And M&A Focus Will Support Future Upside
Analysts have slightly reduced their IDEX price target to $224.29 from $225.08, citing minor model updates to fair value, discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News IDEX completed a share repurchase program announced on April 21, 2008, buying back a total of 19,293,107 shares for US$1,623.91m, representing 24.31% of the company (Key Developments).IEX: Ongoing M&A And Buybacks Will Support Attractive Future Upside
Analysts have raised their price target on IDEX to about $225 from roughly $224, reflecting slightly updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News IDEX is actively pursuing mergers and acquisitions, with management describing the company as about halfway through a multiyear capital deployment cycle focused on building out existing platforms and markets (Key Developments).IEX: Future CFO And Continued M&A Will Support Steady Outlook
Analysts have kept their average IDEX price target broadly steady around $223.54, with only marginal tweaks to inputs such as the discount rate and assumed future P/E multiple to reflect updated views on the company’s risk profile and valuation framework. What's in the News IDEX is actively pursuing mergers and acquisitions, with management indicating they see themselves around the midpoint of a long term capital deployment cycle and planning additional deals to build out existing market positions, using prior acquisition activity as a reference point for future bolt on targets (Key Developments).IEX: Future CFO Transition And Ongoing Buybacks Will Support Steady Outlook
Analysts have lifted their price target on IDEX to $223.54 from $198.62, reflecting updated assumptions that include a slightly lower discount rate and modest tweaks to revenue growth, profit margin, and future P/E expectations. What's in the News IDEX completed a share repurchase tranche between October 1, 2025 and December 31, 2025, buying 400,000 shares, or 0.53% of the company, for $75 million under its long running buyback program announced on April 21, 2008 (Key Developments).IEX: Future CFO Transition And Capital Deployment Will Support Steady Outlook
Analysts have nudged their price target on IDEX higher to about US$199 from roughly US$197, citing updated assumptions that include a slightly lower discount rate, modest tweaks to revenue growth and profit margin expectations, and a marginally higher future P/E estimate. What's in the News IDEX appointed Sean M.IEX: Future CFO Appointment And Buybacks Will Support Steady Outlook
Analysts have modestly raised their fair value estimate for IDEX to US$197.08 from US$194.62, citing slightly lower assumed revenue growth and profit margins that are offset by a higher future P/E multiple and updated discount rate assumptions. What's in the News IDEX appointed Sean M.These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...IDEX Corporation: It's Best To Remain Cautious As Earnings Near
Summary IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns. Awaiting Q1 2025 results on May 1st, IDEX's stock remains fairly valued compared to peers, but not attractive enough for an upgrade. Read the full article on Seeking AlphaIDEX: A Wonderful Mid-Cap Focused On Long-Term Value Generation
Summary IDEX Corporation is a niche industrial manufacturer with a wide economic moat, producing mission-critical products with significant pricing power and high switching costs. Despite softer 2024 earnings, IDEX remains highly profitable with robust margins and a strong balance sheet. The firm's strategic acquisitions and entrenched customer relationships bolster its market position, ensuring continued growth and competitive insulation. Given the fair valuation and conservative fiscal management, I rate IDEX a Hold, awaiting a larger undervaluation for a potential buy. Read the full article on Seeking AlphaIDEX Corporation: A Demanding Valuation For A Great Business
Summary IDEX Corporation faces sluggish organic growth and slower order intake, yet it maintains a strong long-term value proposition through mission-critical industrial and technology solutions. Despite a solid historical performance, current valuation multiples are demanding, especially given the flattish reported results. The company’s recent $1 billion acquisition of Mott is strategically aligned but comes at a high valuation, reflecting IDEX’s increased reliance on M&A for growth. Shares have risen to $235, driven by optimism, but I remain cautious due to lackluster operating performance and heightened expectations at nearly 30 times earnings. Read the full article on Seeking AlphaIDEX Corp. Q2: Project Delay And Weakness In Life Science
Summary I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance. Long-term growth prospects remain strong due to active portfolio management, strategic acquisitions, and anticipated recovery in industrial activities and life science markets by 2025. Read the full article on Seeking AlphaIDEX Corp.: There Are Better Opportunities Out There
Summary IDEX Corporation's revenue grew slightly in 2024, but profitability weakened due to a drop in sales and rising costs. Management remains optimistic about organic revenue growth and adjusted net income for the year. Despite being a high-quality business, IDEX Corporation's shares are not attractively priced, making it a better 'hold' than a 'buy' prospect. Read the full article on Seeking Alpha決済の安定と成長
配当データの取得
安定した配当: IEXの1株当たり配当金は過去10年間安定しています。
増加する配当: IEXの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| IDEX 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (IEX) | 1.2% |
| 市場下位25% (US) | 1.3% |
| 市場トップ25% (US) | 4.0% |
| 業界平均 (Machinery) | 1.2% |
| アナリスト予想 (IEX) (最長3年) | 1.4% |
注目すべき配当: IEXの配当金 ( 1.25% ) はUS市場の配当金支払者の下位 25% ( 1.32% ) と比べると目立ったものではありません。
高配当: IEXの配当金 ( 1.25% ) はUS市場の配当金支払者の上位 25% ( 4% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: IEXの 配当性向 ( 41.4% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: IEXの 現金配当性向 ( 33.6% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。
高配当企業の発掘
企業分析と財務データの現状
| データ | 最終更新日(UTC時間) |
|---|---|
| 企業分析 | 2026/08/24 21:54 |
| 終値 | 2026/08/24 00:00 |
| 収益 | 2026/06/30 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
IDEX Corporation 13 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。28
| アナリスト | 機関 |
|---|---|
| John Eade | Argus Research Company |
| Michael Halloran | Baird |
| Walter Liptak | Barrington Research Associates, Inc. |